YOU ARE HERE:
Resistance news
page  of 9
 
Headline
Date
  Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy
06.08.08
  Low level of drug-resistant strains common in untreated patients, but may not affect treatment
22.07.08
  Untreated HIV infection may facilitate rifampicin-resistant and multi-drug-resistant TB strains
27.06.08
  Boosted protease inhibitors have 60% lower risk of resistance compared with other classes
18.06.08
  High death rates in Peruvian patients defaulting from multi-drug-resistant tuberculosis treatment
12.06.08
  Extensive resistance common in Nigerians failing antiretroviral therapy
05.06.08
  Most viral load blips are short-lasting and of no significance
19.05.08
  Nearly all patients with NNRTI resistance could benefit from etravirine, UK analysis shows
09.05.08
  Planned interruption of highly active antiretroviral therapy does not select drug resistance mutations in HIV-1-infected children
07.05.08
  Dual class drug resistance present in two-thirds of South African HIV cohort on failing ART
05.05.08
  BHIVA: Current tests may miss a third of HIV resistance in treatment-naive
29.04.08
  Don't use azithromycin for gonorrhoea: six cases of high-level resistance in the UK
11.04.08
  Some HIV subtypes may carry natural resistance to tipranavir
20.03.08
  CROI: HAART Breastfeeding study detects drug resistance in HIV-infected infants
08.02.08
  Kaletra monotherapy studies yield conflicting results
28.01.08
  Etravirine (TMC125, Intelence) granted accelerated approval in US
21.01.08
  Balance of evidence continues to show: undetectable viral load in blood does not equal zero infection risk
18.01.08
  Dutch find no evidence of superinfection in patients experiencing virological failure
10.01.08
  Start treatment when CD4 cell count is 350, say revised US guidelines
05.12.07
  HIV superinfection in chronically-infected patients reported
16.11.07

page  of 9